See also this year's filing and all EDGAR filings for this company.
PDF Report 0001576263_2020_Mirati_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001576263, Mirati Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 424,407,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,776,000 |
| 3 | remainder_Assets | 6,017,000 |
| 4 | LiabilitiesCurrent | 48,906,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 999,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 42,573,000 |
| 9 | ResearchAndDevelopmentExpense | 182,866,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 3,335,000 |
| 12 | remainder_NetIncome | 8,848,000 |
| 13 | remainder_ComprehensiveNetIncome | 410,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 432,200,000 |
| 1 | Liabilities | 49,905,000 |
| 2 | Expenses | 225,439,000 |
| 3 | Revenues | 3,335,000 |
| 4 | StockholdersEquity | 382,295,000 |
| 5 | NetIncome | -213,256,000 |
| 6 | ComprehensiveNetIncome | -213,051,000 |
| 7 | BaseVar | 360,068,500 |
| 8 | EconomicCapitalRatio | 1.84 |